Literature DB >> 10834068

Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population.

R Manandhar1, J W LeMaster, C R Butlin, P J Brennan, P W Roche.   

Abstract

New tools for the detection of leprosy exposure in a community will be necessary for the eradication of leprosy. Candidate leprosy skin-test antigens derived from the fractionation of the leprosy bacillus into cytoplasmic and cell-wall proteins free of immuno-inhibitory mycobacterial lipoglycans and carbohydrates were used in an overnight blood test to determine whether exposure to leprosy can be detected by the production of the cytokine interferon gamma (IFN-gamma). Strong IFN-gamma responses were detected in leprosy contacts to both skin-test antigens compared with control subjects from the same endemic communities. There was little response in patients with tuberculosis. Responses were greatest in contacts with recent leprosy exposure. The implications of these findings for the application of these reagents in a field trial as skin tests to detect exposure to leprosy are discussed in light of the strong association between overnight IFN-gamma to PPD and the tuberculin skin-test responses previously reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834068

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  7 in total

1.  A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Authors:  H M Dockrell; S Brahmbhatt; B D Robertson; S Britton; U Fruth; N Gebre; M Hunegnaw; R Hussain; R Manandhar; L Murillo; M C Pessolani; P Roche; J L Salgado; E Sampaio; F Shahid; J E Thole; D B Young
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  High levels of inflammatory cytokines are associated with poor clinical response to steroid treatment and recurrent episodes of type 1 reactions in leprosy.

Authors:  R Manandhar; N Shrestha; C R Butlin; P W Roche
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

3.  Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen.

Authors:  S Brahmbhatt; R Hussain; S Zafar; G Dawood; T H M Ottenhoff; J W Drijfhout; G Bothamley; S Smith; F V Lopez; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Gene expression profile and immunological evaluation of unique hypothetical unknown proteins of Mycobacterium leprae by using quantitative real-time PCR.

Authors:  Hee Jin Kim; Kalyani Prithiviraj; Nathan Groathouse; Patrick J Brennan; John S Spencer
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

5.  The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy.

Authors:  Becky L Rivoire; Stephen TerLouw; Nathan A Groathouse; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

6.  Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.

Authors:  Becky L Rivoire; Nathan A Groathouse; Stephen TerLouw; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Saraswoti Khadge; Chhatra B Kunwar; Chatra B Kunwar; Murdo Macdonald; Rachel Hawksworth; Min B Thapa; Deanna A Hagge; Melinda Tibbals; Carol Smith; Tina Dube; Dewei She; Mark Wolff; Eric Zhou; Mamodikoe Makhene; Robin Mason; Christine Sizemore; Patrick J Brennan
Journal:  PLoS Negl Trop Dis       Date:  2014-05-29

7.  Is TB Testing Associated With Increased Blood Interferon-Gamma Levels?

Authors:  Aideen E Kennedy; Jim O'Mahony; Noel Byrne; John MacSharry; Riona G Sayers
Journal:  Front Vet Sci       Date:  2017-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.